Moderna, Inc. IPO Research Information

Moderna, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Moderna, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Moderna, Inc.	MRNA - NASDAQ	$22.00-$24.00	$23.00	$22.00	26 million	12/7/2018
Underwriter(s): Morgan Stanley, Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch, Barclays, Piper Jaffray
Co-Manager(s): Oddo BHF, Oppenheimer & Co., Needham & Company, Chardan
Industry: Health Care
Filing(s): Filed 2018-11-09 Terms Added 2018-11-28

Moderna, Inc. Quote & Chart - Click for current quote - MRNA

About Moderna, Inc. (adapted from Moderna, Inc. prospectus):
They are creating a new category of transformative medicines based on messenger RNA, or mRNA, to improve the lives of patients.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MRNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.